Summary
This large-scale genetic study mapped protein quantitative trait loci for 90 cardiovascular proteins across over 30,000 individuals, identifying 451 pQTLs and their regulatory pathways. The findings were substantiated through mouse knockdown experiments and clinical trial data, and Mendelian randomization analysis identified 11 proteins with causal links to human disease that represent novel or repositioned drug target opportunities. The work provides a genetic resource for understanding circulating protein regulation relevant to cardiovascular health and precision medicine.
UK applicability
The findings have direct relevance to UK cardiovascular research and drug development pipelines, particularly for understanding genetic variants affecting circulating protein levels in European-ancestry populations well-represented in this international cohort. The identified drug targets may inform future precision medicine approaches to cardiovascular disease prevention and treatment in the UK NHS.
Key measures
Protein quantitative trait loci (pQTL); trans-pQTL gene and regulatory designations; Mendelian randomization for causal inference; mouse knockdown validation; clinical trial evidence
Outcomes reported
The study mapped protein quantitative trait loci (pQTL) for 90 cardiovascular proteins in over 30,000 individuals and identified 451 pQTLs across 85 proteins. Eleven proteins with causal evidence of disease involvement were identified as novel or repositioned drug targets.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.